These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3287601

  • 1. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K.
    Schweiz Med Wochenschr; 1988 Mar 19; 118(11):375-80. PubMed ID: 3287601
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT.
    Contrib Nephrol; 1989 Mar 19; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract] [Full Text] [Related]

  • 6. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M, Mörsdorf S, Jung F, Braun B, Waldhausen P, Pindur G, Weber U, Bosslet R, Bambauer R, Jutzler GA.
    Beitr Infusionsther; 1990 Mar 19; 26():89-95. PubMed ID: 1703909
    [Abstract] [Full Text] [Related]

  • 7. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb 19; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 8. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H, Nakahashi H, Sawanishi K, Kuze M, Ono T.
    Hinyokika Kiyo; 1992 Dec 19; 38(12):1429-35. PubMed ID: 1288237
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
    Borrego FJ, Miguel JL, Zamorano A, Muñoz J, Bajo A, López-Revuelta K, Sánchez Sicilia L.
    Med Clin (Barc); 1991 Nov 23; 97(18):687-92. PubMed ID: 1770818
    [Abstract] [Full Text] [Related]

  • 10. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 23; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 11. Review of patients' responses to epoetin alfa therapy.
    Krantz SB.
    Pharmacotherapy; 1990 Mar 23; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H, Mayer G, Cada EM, Thum J, Stummvoll HK.
    Wien Klin Wochenschr; 1987 Dec 18; 99(24):855-9. PubMed ID: 3439185
    [Abstract] [Full Text] [Related]

  • 13. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB.
    Am J Kidney Dis; 1991 Oct 18; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
    Massetani R, Galli R, Calabrese R, Sartucci F, Rindi P, Severino Brandi L, Murri L.
    Riv Neurol; 1991 Oct 18; 61(6):215-8. PubMed ID: 1813973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.